A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19
Clinical trial NCT05249829 · COMPLETED
Trial details
- NCT number
- NCT05249829
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2023-06-23
- Enrollment
- 3548
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.